Open AccessOlaparib and bevacizumab in front-line maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
Author(s) -
Eduardo Paulino,
Andréia Cristina de Melo
Publication year - 2020
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2020.31.e95
Subject(s) - medicine , olaparib , bevacizumab , ovarian cancer , subgroup analysis , oncology , front line , cancer , chemotherapy , meta analysis , poly adp ribose polymerase , biochemistry , chemistry , polymerase , political science , law , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom